Objective. Several confirmed genetic susceptibility loci for lupus have been described. To date, no clear evidence for genetic epistasis in lupus has been established. The aim of this study was to test for gene-gene interactions in a number of known lupus susceptibility loci.
methods. The false discovery rate (FDR) method was used to correct for multiple testing.
Results. We detected and confirmed gene-gene interactions between the HLA region and CTLA4, IRF5, and ITGAM and between PDCD1 and IL21 in patients with lupus. The most significant interaction detected by parametric analysis was between rs3131379 in the HLA region and rs231775 in CTLA4 (interaction odds ratio 1.19, Z ‫؍‬ 3.95, P ‫؍‬ 7.8 ؋ 10
؊5 [FDR <0.05], P for multifactor dimensionality reduction ‫؍‬ 5.9 ؋ 10 ؊45 ). Importantly, our data suggest that in patients with lupus, the presence of the HLA lupus risk alleles in rs1270942 and rs3131379 increases the odds of also carrying the lupus risk allele in IRF5 (rs2070197) by 17% and 16%, respectively (P ‫؍‬ 0.0028 and P ‫؍‬ 0.0047, respectively).
Conclusion. We provide evidence for gene-gene epistasis in systemic lupus erythematosus. These findings support a role for genetic interaction contributing to the complexity of lupus heritability.
Recent candidate gene and genome-wide association studies led to the discovery and validation of multiple susceptibility loci for systemic lupus erythematosus (SLE) (1) . However, the heritability of lupus cannot be completely explained by the susceptibility loci already discovered. We suggest that the missing heritability in lupus can be explained by 3 potential mechanisms: a heritable epigenetic component, common and rare disease susceptibility variants yet to be discovered, and gene-gene interactions involving known and perhaps yet to be discovered genetic variants for disease susceptibility. The data regarding gene-gene interaction (epistasis) in lupus (2, 3) are very limited and controversial. Consequently, it is widely accepted that the known lupus susceptibility loci operate additively rather than epistatically to increase the risk of lupus.
Herein, we sought to examine gene-gene interactions in some of the previously established and confirmed susceptibility loci for lupus, using a large set of patients with lupus and control subjects. We identified and confirmed 6 novel gene-gene interactions for lupus, using both parametric and nonparametric statistical methods.
PATIENTS AND METHODS
Study participants and genotyping. A total of 4,248 patients with lupus and 3,818 normal healthy control subjects of European descent were included in this study. Eighteen single-nucleotide polymorphisms (SNPs) representing previously confirmed and independent autosomal lupus susceptibility loci were genotyped (Table 1) . A summary of the allelic association results in these loci, based on the patients and controls included in this study, is shown in Table 2 .
Two tag SNPs in the HLA region were genotyped. These 2 SNPs were selected because they were recently shown to have independent genetic effects, by logistic regression analysis of a large number of lupus-associated SNPs in the HLA region (4). Likewise, 3 tag SNPs representing independent genetic susceptibility effects in IRF5 were genotyped (5). All lupus patients fulfilled the American College of Rheumatology criteria for the classification of SLE (6,7). Genotyping was performed using an Illumina custom bead system on an iScan instrument as part of a large lupus candidate gene association study, to reduce the cost of genotyping and maximize sample size. We genotyped 347 ancestry-informative markers in all of the samples included in this study (8) (9) (10) (11) . Individuals with a genotype success rate of Ͻ90% (361 samples) were excluded from the analysis. The remaining samples were then evaluated for duplicates or related individuals, and one individual from each pair was removed (117 samples) if the proportion of alleles shared identical by descent was Ͼ0.4. Samples were assessed for mismatches between the reported sex of the individual and his or her genetic data. One hundred twelve samples were removed from the analysis because they did not meet the following criteria: an assigned male subject was required to have chromosome X heterozygosity of Յ10% and to be heterozygous at rs2557524, and an assigned female subject was required to have chromosome X heterozygosity of Ͼ10% and to be homozygous at rs2557524. The SNP rs2557524 is mapped on a region on chromosomes X and Y that is identical except for this one base. Because of this one-base difference, male subjects generate a heterozygous genotype (due to the presence of both X and Y chromosomes), and female subjects generate a homozygous genotype (due to the presence of only X chromosomes).
Next, samples with increased heterozygosity (Ͼ5 SDs from the mean) were removed from the analysis (n ϭ 5). Finally, 42 genetic outliers, as determined by principal components analysis, were removed from further analysis. An additional 2 outlier samples identified by admixture proportions calculated using AdmixMap were also removed. After the quality control measures detailed above were applied, samples from the following individuals were included in our analysis: 3,936 lupus patients of European descent (3,592 women and 344 men), and 3,491 healthy control subjects of European descent (2,340 women and 1,151 men).
Detection of gene-gene interaction. Testing for genegene interaction was performed sequentially, using 2 independent statistical approaches. First, a parametric analysis for epistasis was applied as implemented in Plink (12) . Epistatic interactions detected using Plink were validated using allelic 2 ϫ 2 tables among lupus patients to calculate interaction odds ratios (ORs) and identify the specific alleles in each SNP pair that contributed to the interaction detected. Allelic 2 ϫ 2 tables ( Figure 1 ) were obtained from 3 ϫ 3 genotypic tables ( Figure 2 ) for each interaction tested. The allelic 2 ϫ 2 tables are based on 4n allele counts, where n is the total number of individuals, with each individual contributing a total of 4 independent alleles. Z scores were calculated as the natural logarithm of the OR divided by the square root of the variance, and associated P values were assigned from the Z scores for each interaction. Chi-square statistics for pairwise interaction were calculated as were chi-square-derived P values. Second, a pairwise nonparametric epistasis test was applied utilizing multifactor dimensionality reduction (MDR) analysis (13, 14) . The false discovery rate (FDR) method as described by Benjamini and Hochberg was used to correct for multiple comparisons (15, 16) .
RESULTS
To test for gene-gene interactions within the known lupus susceptibility loci examined, we performed a 2-step epistasis analysis using a parametric approach, * SNP ϭ single-nucleotide polymorphism; OR ϭ odds ratio; 95% CI ϭ 95% confidence interval.
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followed by a nonparametric analysis. This 2-step approach has the strength of examining and confirming epistatic interactions using 2 independent statistical methods. This is necessary, because the best methodology for detecting gene-gene interaction remains controversial.
We first used a case-only pairwise epistasis analysis implemented in Plink. The case-only analysis was selected because it was shown to be a more powerful test for epistasis compared with case-control analysis (17, 18) . Interactions with an FDR of Յ0.05 were considered established, and those with an FDR of Ͼ0.05 and Յ0.25 were considered suggestive interactions that require confirmation. A high FDR was used in the initial screening for suggestive interactions to avoid excluding true gene-gene interactions from confirmatory analyses.
We identified 6 gene-gene interactions using parametric analysis (Table 3 ). The 2 most significant interactions were between CTLA4 and the 2 SNPs representing 2 independent genetic effects within the HLA region (FDR Յ0.05). The detected epistasis signal between the risk alleles in CTLA4 and rs3131379 (HLA region 1) and CTLA4 and rs1270942 (HLA region 2) showed interaction ORs of 1.19 and 1.18, respectively (Z ϭ 3.95 [P ϭ 7.8 ϫ 10
Ϫ5
] and Z ϭ 3.88 [P ϭ 1.0 ϫ 10 Ϫ4 ], respectively). These data indicated that in lupus patients, the presence of the lupus risk allele in CTLA4 increases the odds of carrying the risk allele in either of the HLA lupus-associated loci by ϳ20%, and vice versa (Figure 1 ). Four additional suggestive gene-gene interactions (FDR Յ0.25) were observed between the HLA region and IRF5, the HLA region and ITGAM, and IL21 and PDCD1 (Table 3 ). The presence of the risk allele in the 2 HLA lupus-associated loci examined (rs1270942 and rs3131379) increased the odds of carrying the lupus risk allele in IRF5 (rs2070197) by 17% and 16%, respectively, and vice versa (P ϭ 0.0028 and P ϭ 0.0047, respectively). Interestingly, our data suggested that the presence of the risk allele in ITGAM increases the odds of carrying the protective allele in rs3131379 (HLA) by 16% (P ϭ 0.0075).
Next, and in order to confirm the 2 gene-gene interactions that we established using parametric tests, and to test whether the other 4 suggestive gene-gene interactions can be established, we applied MDR analysis to the interactions initially identified using parametric analysis. The MDR is a nonparametric test for nonlinear epistasis. A pairwise MDR analysis was applied to test the specific interactions detected using parametric analysis. It should be noted, however, that * Cross-validation consistency reflects the number of times MDR analysis identified the same model as the data were divided into different segments. Balanced accuracy is defined as (sensitivity ϩ specificity)/2, where sensitivity ϭ true positives/(true positives ϩ false negatives), and specificity ϭ true negatives/(false positives ϩ true negatives). This gives an accuracy estimate that is not biased by the larger class (37) .
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results obtained using the MDR nonparametric analysis reflect a joint effect consisting of the main genetic association effect in the loci examined and the interaction effect. These results are presented in Table 4 (also see Supplementary Table 1 
DISCUSSION
The nature and very existence of genetic epistasis in lupus have been elusive. We combined the strengths of 2 independent approaches to test for genetic epistasis in lupus and identified several novel gene-gene interactions, using a large sample derived from individuals of European descent. The most significant interaction identified was between the HLA region and CTLA4. Indeed, 2 independent lupus-associated SNPs within the HLA region (rs3131379 and rs1270942) showed evidence for significant interaction with rs231775 in CTLA4 (Tables 3 and 4 ). The HLA-CTLA4 interaction in lupus underscores antigen presentation and T cell stimulation as important processes involved in the pathogenesis of lupus. This interaction is biologically logical, because CTLA-4 is up-regulated on T cells following T cell activation by antigen-presenting cells (19) . Following T cell activation via binding of the major histocompatibility complex-antigen complex to the T cell receptor (signal 1), the binding of CD80/CD86 on antigenpresenting cells to CD28 on the surface of T cells (signal 2) ensures T cell activation and interleukin-2 (IL-2) production (19) . CTLA-4 competes with CD28 to bind CD80/CD86 and provides a negative signal that suppresses T cell activation. This process is thought to be important to control T cell activation and prevent autoimmunity.
A role for antigen-presenting cells in lupus is highlighted again with the HLA-ITGAM gene-gene interaction, although this interaction is between the risk and protective alleles in these 2 loci. ITGAM (integrin, alpha M) encodes for CD11b, the ␣ chain in the integrin molecule CD11b/CD18 (Mac-1, CR3). It is expressed on the surface of antigen-presenting cells and neutrophils and plays a role in cell-cell adhesions, leukocyte extravasation, and in complement-mediated phagocytosis of C3bi-opsonized antigens (20, 21) .
We also showed evidence for gene-gene interaction between the 2 independent lupus-associated SNPs within the HLA region and rs2070197 in IRF5. This interaction emphasizes the role of the interferon pathway in the pathogenesis of lupus.
The other gene-gene interaction that we identified was between rs907715 in IL21 and rs11568821 in PDCD1. This interaction is very interesting, because it highlights a role for follicular helper T (Tfh) cells in lupus. High PDCD1 expression and IL-21 production are hallmarks of Tfh cells (22) . Tfh cells promote germinal center formation, plasma cell differentiation, and antibody isotype switching (23) . PDCD1 deficiency results in impaired germinal center B cell survival and diminished production of long-lived plasma cells (24) . Indeed, the production of IL-21 is reduced in Tfh cells from Pdcd1 Ϫ/Ϫ mice (24) . IL-21 deficiency results in impaired germinal center formation, plasma cell differentiation, and isotype class switching (23) , emphasizing a central role for IL-21 in Tfh cell function. Of interest, a higher fraction of circulating Tfh cells was detected in the peripheral blood of patients with lupus compared with normal control subjects (25) .
In summary, we provided strong evidence that in patients with lupus, the presence of one risk allele can influence the presence or absence of other risk alleles, across different loci. We have identified novel genegene epistatic interactions in lupus. Gene-gene interactions might help explain at least part of the "missing heritability" in complex diseases. Our findings provide evidence against a simple "additive" genetic model in autoimmunity and highlight antigen presentation and T cell activation, the interferon pathway, and Tfh cells as important contributors to the pathogenesis of lupus.
